LSV Asset Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
17,959
-1,900
-10% -$126K ﹤0.01% 647
2026
Q1
$1.23M Buy
19,859
+6,385
+47% +$402K ﹤0.01% 621
2025
Q4
$754K Buy
13,474
+500
+4% +$29K ﹤0.01% 661
2025
Q3
$817K Hold
12,974
﹤0.01% 654
2025
Q2
$738K Buy
12,974
+1,053
+9% +$57.3K ﹤0.01% 634
2025
Q1
$668K Buy
11,921
+1,700
+17% +$102K ﹤0.01% 661
2024
Q4
$628K Sell
10,221
-3,600
-26% -$233K ﹤0.01% 651
2024
Q3
$925K Hold
13,821
﹤0.01% 644
2024
Q2
$923K Hold
13,821
﹤0.01% 685
2024
Q1
$983K Sell
13,821
-2,623
-16% -$197K ﹤0.01% 686
2023
Q4
$1.39M Sell
16,444
-2,771
-14% -$230K ﹤0.01% 656
2023
Q3
$1.65M Sell
19,215
-1,400
-7% -$129K ﹤0.01% 635
2023
Q2
$1.92M Sell
20,615
-3,885
-16% -$366K ﹤0.01% 629
2023
Q1
$2.32M Buy
24,500
+11,686
+91% +$1.07M 0.01% 591
2022
Q4
$1.29M Buy
12,814
+1,913
+18% +$175K ﹤0.01% 630
2022
Q3
$930K Sell
10,901
-1,799
-14% -$159K ﹤0.01% 652
2022
Q2
$1.09M Sell
12,700
-400
-3% -$34.1K ﹤0.01% 664
2022
Q1
$1.18M Buy
+13,100
New +$1.2M ﹤0.01% 689

Other funds holding UTMD

LSV Asset Management's UTMD Position: Q2 2026 in Review

LSV Asset Management reduced its Utah Medical Products (UTMD) stake by 9.6% in Q2 2026, selling an estimated $126K and leaving 17,959 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #647.

LSV Asset Management first reported a position in UTMD in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.32M in Q1 2023. 50 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • LSV Asset Management held 17,959 shares of Utah Medical Products worth $1.24M as of Q2 2026.
  • LSV Asset Management sold 1,900 Utah Medical Products shares in Q2 2026, an estimated $126K.
  • Utah Medical Products made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #647 holding.
  • LSV Asset Management first reported a position in Utah Medical Products in Q1 2022 and has held it in 18 quarters since.
  • LSV Asset Management's Utah Medical Products position peaked at $2.32M in Q1 2023.
  • 50 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.